BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2183633)

  • 1. Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial.
    Kagan BL; Sultzer DL; Rosenlicht N; Gerner RH
    Am J Psychiatry; 1990 May; 147(5):591-5. PubMed ID: 2183633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-adenosylmethionine treatment of depression: a controlled clinical trial.
    Bell KM; Plon L; Bunney WE; Potkin SG
    Am J Psychiatry; 1988 Sep; 145(9):1110-4. PubMed ID: 3046382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open trial of S-adenosylmethionine for treatment of depression.
    Lipinski JF; Cohen BM; Frankenburg F; Tohen M; Waternaux C; Altesman R; Jones B; Harris P
    Am J Psychiatry; 1984 Mar; 141(3):448-50. PubMed ID: 6367496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAMe versus placebo: a double blind comparison in major depressive disorders.
    Muscettola G; Galzenati M; Balbi A
    Adv Biochem Psychopharmacol; 1982; 32():151-6. PubMed ID: 7046362
    [No Abstract]   [Full Text] [Related]  

  • 5. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies.
    Bressa GM
    Acta Neurol Scand Suppl; 1994; 154():7-14. PubMed ID: 7941964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine.
    Bottiglieri T; Godfrey P; Flynn T; Carney MW; Toone BK; Reynolds EH
    J Neurol Neurosurg Psychiatry; 1990 Dec; 53(12):1096-8. PubMed ID: 2292704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study.
    Frezza M; Surrenti C; Manzillo G; Fiaccadori F; Bortolini M; Di Padova C
    Gastroenterology; 1990 Jul; 99(1):211-5. PubMed ID: 2188871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early clinical double-blind study with S-adenosyl-L-methionine: a new potential antidepressant.
    Küfferle B; Grünberger J
    Adv Biochem Psychopharmacol; 1982; 32():175-80. PubMed ID: 7046363
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of S-adenosylmethionine (SAM) on prolactin in depressed patients.
    Thomas CS; Bottiglieri T; Edeh J; Carney MW; Reynolds EH; Toone BK
    Int Clin Psychopharmacol; 1987 Apr; 2(2):97-102. PubMed ID: 3298421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapidity of onset of the antidepressant effect of parenteral S-adenosyl-L-methionine.
    Fava M; Giannelli A; Rapisarda V; Patralia A; Guaraldi GP
    Psychiatry Res; 1995 Apr; 56(3):295-7. PubMed ID: 7568552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled study of S-adenosyl-L-methionine in depressed postmenopausal women.
    Salmaggi P; Bressa GM; Nicchia G; Coniglio M; La Greca P; Le Grazie C
    Psychother Psychosom; 1993; 59(1):34-40. PubMed ID: 8441793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind trial.
    Arana GW; Santos AB; Laraia MT; McLeod-Bryant S; Beale MD; Rames LJ; Roberts JM; Dias JK; Molloy M
    Am J Psychiatry; 1995 Feb; 152(2):265-7. PubMed ID: 7840362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antidepressant potential of oral S-adenosyl-l-methionine.
    Rosenbaum JF; Fava M; Falk WE; Pollack MH; Cohen LS; Cohen BM; Zubenko GS
    Acta Psychiatr Scand; 1990 May; 81(5):432-6. PubMed ID: 2113347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
    Lecrubier Y; Clerc G; Didi R; Kieser M
    Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate in mild depression: a double-blind controlled trial.
    Mattes JA
    J Clin Psychiatry; 1985 Dec; 46(12):525-7. PubMed ID: 3905773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controlled double-blind study (SAMe-imipramine) in depressive syndromes].
    Mantero M; Pastorino P; Carolei A; Agnoli A
    Minerva Med; 1975 Nov; 66(78):4098-101. PubMed ID: 1103017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression.
    Bauer M; Bschor T; Kunz D; Berghöfer A; Ströhle A; Müller-Oerlinghausen B
    Am J Psychiatry; 2000 Sep; 157(9):1429-35. PubMed ID: 10964859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral SAMe in persistent treatment-refractory bipolar depression: a double-blind, randomized clinical trial.
    Murphy BL; Babb SM; Ravichandran C; Cohen BM
    J Clin Psychopharmacol; 2014 Jun; 34(3):413-6. PubMed ID: 24699040
    [No Abstract]   [Full Text] [Related]  

  • 19. SAMe (S-adenosylmethionine).
    Echols JC; Naidoo U; Salzman C
    Harv Rev Psychiatry; 2000; 8(2):84-90. PubMed ID: 10902097
    [No Abstract]   [Full Text] [Related]  

  • 20. S-adenosylmethionine blood levels in major depression: changes with drug treatment.
    Bell KM; Potkin SG; Carreon D; Plon L
    Acta Neurol Scand Suppl; 1994; 154():15-8. PubMed ID: 7941961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.